|
⚲
|
| Keyboard |
| Mpm BioVentures V LLC | |
|---|---|
| Firm | MPM Asset Management LLC |
| Address | Mpm Asset Management LLC 200 Clarendon Street, 54th Floor Boston, MA 02116 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| MPM Asset Management LLC | |||||
| MPM BioVentures V LP | 021-138701 | Promoter | 69.1 M | 12.6 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals Inc RYTM
Common Stock
|
2017-10-10 | Conversion | 2,567,014 | ||
|
Rhythm Pharmaceuticals Inc RYTM
Common Stock
|
2017-10-10 | Buy | 100,000 | $17.00 | 1,700,000 |
|
Rhythm Pharmaceuticals Inc RYTM
Series A-1 Junior Preferred Stock · derivative
|
2017-10-10 | Conversion | 15,887,703 | $0.00 | |
|
Rhythm Pharmaceuticals Inc RYTM
Series A Preferred Stock · derivative
|
2017-10-10 | Conversion | 7,651,831 | $0.00 | |
|
Avalo Therapeutics Inc CERC
Common Stock
|
2015-10-20 | Conversion | 595,436 | ||
|
Avalo Therapeutics Inc CERC
Series B Convertible Preferred Stock · derivative
|
2015-10-20 | Conversion | 16,672,224 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-10 | Sell | 600,000 | $20.02 | 12,012,000 |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 20,876 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 37,117 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 1,000,000 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 20,876 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 12,247 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 20,876 | $0.00 | |
|
Aratana Therapeutics Inc PETX
Common Stock
|
2014-03-03 | Other | 15,310 | $0.00 | |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Other | 16,716 | $11.00 | 183,876 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Buy | 165,265 | $11.00 | 1,817,915 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Conversion | 1,010,099 | ||
|
Histogen Inc CNAT
Warrant to Purchase Common Stock (Right to Buy) · derivative
|
2013-07-30 | Conversion | 32,220 | $0.00 | |
|
Histogen Inc CNAT
Warrant to Purchase Series B Preferred Stock (Right to Buy) · derivative
|
2013-07-30 | Conversion | 265,837 | $0.00 | |
|
Histogen Inc CNAT
Series B Convertible Preferred Stock · derivative
|
2013-07-30 | Conversion | 8,333,334 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||